Merck gets Chinese approval for Welireg for VHL tumors
| STVTX Fund | USD 12.80 0.01 0.08% |
Slightly above 56% of Ridgeworth Ceredex's investor base is looking to short. The analysis of overall sentiment of trading Ridgeworth Ceredex Large mutual fund suggests that many investors are alarmed at this time. Ridgeworth Ceredex's investing sentiment can be driven by a variety of factors including economic data, Ridgeworth Ceredex's earnings reports, geopolitical events, and overall market trends.
Ridgeworth |
Merck has received Chinese regulatory approval for its drug Welireg for the treatment of certain types of Von Hippel-Lindau disease-associated tumors. Read more here.
Read at seekingalpha.com
 |
Ridgeworth Ceredex Fundamental Analysis
We analyze Ridgeworth Ceredex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ridgeworth Ceredex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ridgeworth Ceredex based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Ridgeworth Ceredex is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Ridgeworth Ceredex Large Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ridgeworth Ceredex mutual fund to make a market-neutral strategy. Peer analysis of Ridgeworth Ceredex could also be used in its relative valuation, which is a method of valuing Ridgeworth Ceredex by comparing valuation metrics with similar companies.
Peers
Ridgeworth Ceredex Related Equities
| SAGAX | Ridgeworth Innovative | 0.95 | ||||
| SAINX | Ridgeworth Seix | 0.40 | ||||
| SAMFX | Ridgeworth Seix | 0.32 | ||||
| SAMHX | Ridgeworth Seix | 0.13 | ||||
| HYIZX | Ridgeworth Seix | 0.13 | ||||
| HYPSX | Ridgeworth Seix | 0.13 | ||||
| SSAGX | Virtus Seix | 0.10 | ||||
| SAMBX | Ridgeworth Seix | 0.00 | ||||
| VMSSX | Virtus Multi-sector | 0.00 | ||||
| VMSAX | Virtus Multi-strategy | 0.22 |
Other Information on Investing in Ridgeworth Mutual Fund
Ridgeworth Ceredex financial ratios help investors to determine whether Ridgeworth Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ridgeworth with respect to the benefits of owning Ridgeworth Ceredex security.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stocks Directory Find actively traded stocks across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |